In the evening of 1st POD, given the patient’s advanced age and the two-hour duration of the surgery, subcutaneous low-molecular-weight heparin (4100 anti-factor Xa IU) was administered to prevent deep vein thrombosis (DVT). This evidence concerns the gene F10 and deep vein thrombosis.